CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Helius Medical Technologies Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Helius Medical Technologies Inc
642 Newtown Yardley Road
Phone: (215) 944-6100p:215 944-6100 NEWTOWN, PA  18940  United States Ticker: HSDTHSDT

Business Summary
Helius Medical Technologies, Inc. is a neurotechnology company. The Company is engaged in the medical device field focused on neurologic deficits using an orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms and promote neuroplasticity, improving the lives of people dealing with neurologic diseases. The Company’s first commercial product is the Portable Neuromodulation Stimulator (PoNS), is a non-implantable medical device, inclusive of a controller and mouthpiece, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. PoNS Therapy utilizes the PoNS device in conjunction with supervised therapeutic exercise. The PoNS Therapy consists of condition-specific exercises for movement control, including balance and gait training and breathing and awareness training, which are tailored to focus on the individual patient’s functional deficits.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/202412/31/2024YesYes--Yes

Industries
SIC Code Description
3845 Electromedical and electrotherapeutic apparatus

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Independent Chairman of the Board BlaneWalter 54 8/1/2020 12/29/2015
President, Chief Executive Officer, Director Dane C.Andreeff 59 6/14/2021 8/4/2017
Chief Financial Officer, Treasurer, Secretary, Director Jeffrey S.Mathiesen 64 5/1/2022 6/9/2020
4 additional Officers and Directors records available in full report.

Business Names
Business Name
Helius Canada Acquisition Ltd.
Helius Medical, Inc.
Heuro Canada, Inc.
4 additional Business Names available in full report.

General Information
Number of Employees: 21 (As of 12/31/2024)
Outstanding Shares: 6,126,778 (As of 3/18/2025)
Shareholders: 37
Stock Exchange: NASD
Fax Number: (302) 655-5049


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, April 19, 2025